Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
about
The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIEA role for SKIP in EBNA2 activation of CBF1-repressed promotersAn Epstein-Barr virus protein interacts with NotchEpstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesEpstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1Structural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIHProtein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1.Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptovirusesSignaling activities of gammaherpesvirus membrane proteinsNotch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promotersDirect and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virusThe human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenanceThe Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promotertrans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJkAn EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP geneEpstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation.Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activationThe Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.Immune regulation in Epstein-Barr virus-associated diseasesIdentification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function.EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.
P2860
Q24329182-3A15BA51-E32C-4113-A477-8E0F47E851F8Q24524363-B362D45B-5BD6-42D7-97E9-2728EACE8A7FQ24529019-EC386CF3-EE48-445F-AE27-A0EBD16F4754Q24540313-7684CDB1-01C1-49D6-B735-10080145CB4BQ24564767-4BBBCA3D-EAB4-4946-B78A-BD03FA9CC4F8Q24646670-44A036D9-6D17-4F19-8BA7-5A1DC30DB4FCQ24681418-0128A4B4-2767-46BC-AE49-14A5B053289CQ27682610-F3A72E7E-B0A1-4D0E-8862-56322B98933FQ28114910-58453DB7-273E-45FA-9D3D-41EF1D98C566Q28579505-09265D73-894B-4B4A-A5A3-524C171B57D4Q33639938-9FB0231F-A7F8-41A3-8BDD-FB1034235097Q33786088-4E0BEAF4-F832-4815-9378-9BD360FD1454Q33792860-0B1D9306-937F-4E79-831B-F71AF9EF1B4EQ33795078-5A6206E6-3740-4DCD-9615-84D544958A29Q33822504-C943F87F-471F-41D3-92B7-46BC8C02C1AAQ33842309-B767E1FF-BE09-466B-91E0-35A731E35AD5Q33845947-A6566ED8-FE73-4092-8AE8-92BCCDF121F6Q33851043-9F43D186-A95A-4DC4-8517-8DB9B10CD1F7Q33865166-CDC5AEDE-BA9B-4CC4-B5FB-EF6AE32552A7Q34327455-852C817F-86C2-4F68-B61B-547F2C2666ACQ34334212-BF522D20-C442-491E-88FD-ACC4939F6F4CQ34341875-E65DCA9A-C97F-4817-96EB-28FEFE913E66Q34355226-DC7F6438-246F-4152-973C-5747E8EB99EEQ35363296-82ACFA39-5556-4DBA-B08F-9A12EF9429A3Q35634286-F425618E-D092-4EF0-90DA-50CEB9FE3E94Q35648541-5F802D08-B1D4-47D3-9584-EDD6E755C5C0Q35829475-F96F5820-2E46-426D-863B-513321F65770Q35830605-72D7C51E-7382-4ACA-AB0C-B50FCB39E774Q35835726-9F788C41-6D10-4D68-825F-C36E06789B52Q35838226-4F6F3BF7-F740-4C7C-BBD4-474843044E09Q35839108-74CEB532-A99A-40FD-9EFB-0EFEE47ECA58Q35852557-9778D610-6125-489E-BCF2-F82EA0E391FAQ35859057-8FEE83DF-3FB4-4A65-812B-961D6145CC7DQ35891360-522C8ED3-FC47-4D78-8889-A832AA4DECEAQ36581891-16CE5767-39AB-4EFF-9E83-B2322CC58564Q36635773-44726ACB-4E4F-411B-B4E6-02CEE610762FQ36669953-D4F4B9A3-53FE-4120-8F86-7D32DAF0B8DBQ36697355-27C015DF-71CD-4FC5-B333-51D613D8A9CDQ37009375-F5891181-B28E-4E8E-A6CD-E5066E5117DEQ37093792-1C4A34E9-297D-4E4D-9367-0C182B701F01
P2860
Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Delineation of the cis-acting ...... n membrane protein expression.
@en
type
label
Delineation of the cis-acting ...... n membrane protein expression.
@en
prefLabel
Delineation of the cis-acting ...... n membrane protein expression.
@en
P2093
P2860
P1433
P1476
Delineation of the cis-acting ...... n membrane protein expression.
@en
P2093
P2860
P304
P407
P577
1991-12-01T00:00:00Z